openPR Logo
Press release

Clinical Trial Imaging Market Growth and Business Opportunities in Coming Years | Leading Companies parexel and ICON PLC

12-16-2019 06:35 AM CET | Health & Medicine

Press release from: MarketsandMarkets.com

Clinical Trial Imaging Market Growth and Business

The report "Clinical Trial Imaging Market Size & Share by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), Product & Services (Software), End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021" is about the current global market trends of the clinical trial imaging industry.

Along with that, the report also outlines the various challenges and future estimates of this market. It is estimated that the global clinical trial imaging market size will reach USD 1,069.7 million by 2021 from USD 773 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Pharmaceutical and biotechnology industries are to drive the growth of the clinical trial imaging industry as they have significantly increased their R&D spending in this area.

Please provide your specific interest in this report so as to help you better, Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30446624&utm_source=openpr-16-12-19

The service segment is projected to lead the clinical trial imaging market.

Growth in this segment is because of an increase in the outsourcing of the work by pharmaceutical & biotechnology companies as well as medical device companies to Contract Research Organizations or CROs and other service providers. The services segment is divided further into reader services, systems & technical support services, operational imaging services, and design consulting services. The operational imaging services segment offers different imaging modalities, which include CT, PET, MRI among others. These imaging modalities form the core services of this segment and of the clinical trial imaging market which is why the operational imaging services segment will have the largest revenue share in 2016. From among these modalities, the CT segment constitutes the largest share in the market. This is because of the usefulness of the CT scans in detecting injuries and cancerous tumors in the body. The PET modality is also expected to grow at the highest CAGR in 2016.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=30446624&utm_source=openpr-16-12-19

The pharmaceutical companies are expected to capture a significant share of the clinical trial imaging market by end-user.

As mentioned before, the pharmaceutical companies have increased their R&D spending which is driving this end-user segment. While pharmaceutical companies are expected to have the lion’s share of the global market, the medical device manufacturing industry is projected to witness the highest CAGR in the forecast period of 2016 to 2021. R&D spending and expansion of the medical devices market will fuel the medical device manufacturing industry.

North America: The globally leading clinical trial imaging market

The US, Canada, and Mexico are the major countries of this region. Growth in CROs, pharmaceutical, and biotechnology companies, along with their increased investment in R&D spending, are factors that will contribute to North America having the largest share in the global market. However, it is Asia Pacific that is projected to grow at the highest CAGR in the forecast period of 2016 to 2021. The factors that will lead to Asia Pacific’s rise are the emergence of biotechnology and pharmaceutical industries and higher R&D spending.

The leading players in the global clinical trial imaging market include BioClinica, Inc. (US), Biomedical Systems (US), Cardiovascular Imaging Technologies (US), BioTelemetric, Inc. (US), ICON Public Limited Company (Ireland), IXICO, PLC (UK), Intrinsic Imaging, LLC (US), PAREXEL International Corporation (US), WorldCare Clinical, LLC (US), and Radiant Sage, LLC (US).

Request for Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=30446624&utm_source=openpr-16-12-19

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Imaging Market Growth and Business Opportunities in Coming Years | Leading Companies parexel and ICON PLC here

News-ID: 1879447 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are